Promega Corporation

Discover Glo: Bioluminescent Cell-Based Assay Seminar Tour – London

Celebrating the launch of NanoLuc®, the most exciting new luciferase – and featuring presentations by leaders in the cellular analysis field, plus updates on the most recent products and technologies for cellular analysis from Promega.

Take the opportunity to network with fellow scientists and speakers during breaks and lunch in the historical surroundings of the Hotel Russell in London.

  • The Hotel Russell in London. See map
  • Date: Tuesday, March 5, 2013
  • Time: 9:30 AM - 4:15 PM

Contact: hilary.latham@promega.com

Bioluminescent Cell-Based Assay Seminar Tour – London Event

The Agenda:

09.30 - 10.00 Arrival, register (entry into the prize draw) & coffee
10.00 - 10.10

Welcome Address

Matt Cook (Head of Commercial Sales, Promega UK)
10.10 - 11.00

NanoLuc® Luciferase: A Smaller, Brighter & More Versatile Luciferase Reporter

Dr Terry Riss, Promega Corporation, Madison
Abstract and Biography »
11.00 - 11.45

Development of Cell-Based Assays to Investigate Modulators of SIRT1 Activity

Dr Vad Lazari, BioFocus
Abstract and Biography »
11.45 - 12.10 Coffee
12.10 - 13.00

Generating Metabolically Active Hepatocytes From Pluripotent Stem Cells

Dr David Hay, Principal Investigator, MRC Centre for Regenerative Medicine, University of Edinburgh
Abstract and Biography »
13.00 - 14.00 Lunch
14.00 - 14.45

A Novel Cell-Based Screening Approach for the Identification of FOXA1 Pathway Inhibitors for the Treatment of Tamoxifen-Resistant Breast Cancer

Dr Aurore Lejeune, Cancer Research Technology, London
Abstract »
14.45 - 15.10

The LIMD1 Protein Bridges an Association between the Prolyl Hydroxylases and VHL to Repress HIF1 Activity

Dr Daniel Foxler, Barts Cancer Centre
Abstract and Biography »
15.10 - 15.50

Cell-Based Assays to Detect the Mechanism of Toxicity

Dr Terry Riss, Promega Corporation, Madison
Abstract and Biography »
15.50 - 16.15 Wrap up, coffee and prize draw for iPad Mini

Prefer a different language?

Your country is set to Poland. Your language is set to polski. Please select the language that will best suit your needs:

This is correct, continue to site »

I need additional help

It appears that you have Javascript disabled. Our website requires Javascript to function correctly. For the best browsing experience, please enable Javascript.